TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
MyHealthChecked PLC ( (GB:MHC) ) has issued an update.
MyHealthChecked PLC has announced the conditional sale of its subsidiary, Concepta Diagnostics Limited, to Boots UK Limited for £2.375 million. This move, pending shareholder approval, will transform MyHealthChecked into an AIM Rule 15 cash shell, with plans to explore strategic options to maximize shareholder value. The sale is part of a broader strategy to leverage Boots’ expertise in retail and pharmacy to expand the reach of home-testing services. The company acknowledges that maintaining Concepta as a standalone business would likely result in continued losses, thus the sale is deemed beneficial for shareholders. Additionally, board changes will occur, with Penelope McCormick resigning to join Boots, and Adam Reynolds becoming Executive Chairman.
More about MyHealthChecked PLC
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted UK healthcare company specializing in at-home healthcare and wellness tests. The company offers a range of rapid self-tests and sample collection kits for DNA, RNA, and blood, which are analyzed in partner laboratories. These products are available both online and over-the-counter, focusing on accessibility and affordability.
Average Trading Volume: 41,077
Technical Sentiment Signal: Sell
Current Market Cap: £5.19M
Find detailed analytics on MHC stock on TipRanks’ Stock Analysis page.